• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

FDA Advisory on Triptans and SSRI/SNRIs Will Not Affect Migraine Treatment, Say Experts

by Heather Lindsey • October 1, 2006

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

A study that evaluated the tolerability and safety of combining other medications in patients taking subcutaneous sumatriptan found that 1,784 of the 12,339 migraine patients were on SSRIs and subcutaneous sumatriptan during a one-year period, and none experienced serotonin syndrome (Cephalalgia 1999;19:668–675), said Dr. Tepper.

You Might Also Like

  • Triptans Prove Helpful in Treating ‘Sinus Headaches
  • FDA Guidance on Sinusitis and Its Potential Impact on Treatment
  • Wrong Diagnosis of Sinus Headache Can Lead to Inappropriate Treatment
  • Migraine-Associated Dizziness Is Elusive to Diagnose
Explore This Issue
October 2006

Most experts said that the data indicate that triptans are safe in combination with SSRIs. But it is also true that most headache specialists, including those interviewed for this article, are involved in the commercial promotion or development of triptans, noted Dr. Shapiro. “It’s hard to find an expert who has not been commercially involved in this class of medicines,” he said.

Treatment Will Not Change

None of the migraine experts recommended that the combination of triptans and SSRIs or SNRIs be discontinued unless symptoms arise.

“I say, ‘If you’re feeling intoxicated, feel sick, get clumsy on your feet, start to twitch, then stop taking the medications,’” Dr. Tepper said. He also recommends trying a non-SSRI or non-SNRI alternative for depression or anxiety and continuing triptans for migraine.

Richard Lipton, MD, Director of the Montefiore Headache Unit and Professor of Neurology at the Albert Einstein College of Medicine, agreed that the risks and benefits of treatment should be discussed with patients. “Patients should be told that serotonin syndrome is a rare complication of medical therapy,” he added.

Patients on SSRIs or SNRIs and triptans should avoid other drugs that act on the serotonin system and keep the dose on the lower end of the safe dose range for triptans, explained Dr. Lipton.

The Bottom Line

Overall, the FDA advisory is based on a preliminary data analysis, noted Dr. Shapiro. The fine print of the Healthcare Professional Sheet with FDA Alert states, “FDA is considering, but has not reached a final conclusion about this information. FDA intends to update this sheet when additional information or analyses become available. “The FDA advisory is premature and their fine print is very apt,” Dr. Shapiro concluded.

Symptoms of Serotonin Syndrome

  • Restlessness
  • Hallucinations
  • Loss of coordination
  • Fast heartbeat
  • Rapid changes in blood pressure
  • Increased body temperature
  • Overactive reflexes
  • Nausea
  • Vomiting
  • Diarrhea

©2006 The Triological Society

Pages: 1 2 3 | Single Page

Filed Under: Departments, Head and Neck, Medical Education, Practice Focus Tagged With: medication, migraines, research, serotonin, treatment, triptansIssue: October 2006

You Might Also Like:

  • Triptans Prove Helpful in Treating ‘Sinus Headaches
  • FDA Guidance on Sinusitis and Its Potential Impact on Treatment
  • Wrong Diagnosis of Sinus Headache Can Lead to Inappropriate Treatment
  • Migraine-Associated Dizziness Is Elusive to Diagnose

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you use AI-powered scribes for documentation?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • How to: Positioning for Middle Cranial Fossa Repair of Superior Semicircular Canal Dehiscence

    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • The Importance of Time Away
    • Endoscopic Ear Surgery: Advancements and Adoption Challenges 
    • Reflections from a Past President of the Triological Society
    • ENT Surgeons Explore the Benefits and Challenges of AI-Powered Scribes: Revolutionizing Documentation in Healthcare
    • How To: Open Expansion Laryngoplasty for Combined Glottic and Subglottic Stenosis

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939